Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations
- PMID: 24761005
- DOI: 10.1152/ajprenal.00039.2014
Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations
Abstract
Unconjugated bilirubin is an endogenous circulating antioxidant, bound to albumin, and therefore is retained in the vascular compartment. Bilirubin has well-documented neurotoxic effects in infants; however, current evidence indicates mildly elevated bilirubin is associated with protection from cardiovascular disease and all-cause mortality in adults. Recent clinical studies show mildly elevated bilirubin is associated with protection from kidney damage and dysfunction, in addition to cardiovascular events and all-cause mortality in patients undergoing hemodialysis. This is the first review to examine the clinical evidence and summarize the potential mechanisms of action that link bilirubin to protection from kidney damage, subsequent kidney failure, and dialysis-related mortality. With this understanding, it is hoped that new therapies will be developed to prevent renal dysfunction and mortality from cardiovascular disease in at-risk individuals.
Keywords: NADPH oxidase; all-cause mortality; antioxidant; bile pigment; hemodialysis; tetrapyrrole.
Copyright © 2014 the American Physiological Society.
Similar articles
-
Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk.Nephrology (Carlton). 2012 Jul;17(5):433-44. doi: 10.1111/j.1440-1797.2012.01618.x. Nephrology (Carlton). 2012. PMID: 22574672 Review.
-
Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.Clin J Am Soc Nephrol. 2011 Mar;6(3):567-74. doi: 10.2215/CJN.06130710. Clin J Am Soc Nephrol. 2011. PMID: 21411679 Free PMC article.
-
Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.Clin J Am Soc Nephrol. 2012 Apr;7(4):541-8. doi: 10.2215/CJN.09420911. Epub 2012 Feb 2. Clin J Am Soc Nephrol. 2012. PMID: 22300737
-
Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases.Clin Sci (Lond). 2015 Jul;129(1):1-25. doi: 10.1042/CS20140566. Clin Sci (Lond). 2015. PMID: 25881719 Review.
-
Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.Clin Nephrol. 2013 Sep;80(3):161-7. doi: 10.5414/CN107803. Clin Nephrol. 2013. PMID: 23547804 Clinical Trial.
Cited by
-
Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy).Pharmaceuticals (Basel). 2023 Jul 28;16(8):1077. doi: 10.3390/ph16081077. Pharmaceuticals (Basel). 2023. PMID: 37630992 Free PMC article. Review.
-
Total Bilirubin in Prognosis for Mortality in End-Stage Renal Disease Patients on Peritoneal Dialysis Therapy.J Am Heart Assoc. 2017 Dec 23;6(12):e007507. doi: 10.1161/JAHA.117.007507. J Am Heart Assoc. 2017. PMID: 29275374 Free PMC article.
-
Serum bilirubin and kidney function: a Mendelian randomization study.Clin Kidney J. 2022 May 2;15(9):1755-1762. doi: 10.1093/ckj/sfac120. eCollection 2022 Sep. Clin Kidney J. 2022. PMID: 36003670 Free PMC article.
-
Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank.Cardiovasc Diabetol. 2022 Apr 18;21(1):54. doi: 10.1186/s12933-022-01484-x. Cardiovasc Diabetol. 2022. PMID: 35436955 Free PMC article.
-
A new parameter for predict the clinical outcome of patients with COVID-19 pneumonia: The direct/total bilirubin ratio.Int J Clin Pract. 2021 Oct;75(10):e14557. doi: 10.1111/ijcp.14557. Epub 2021 Jul 16. Int J Clin Pract. 2021. PMID: 34157182 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical